# COVID-19 Immune Repertoire Sequencing

> **NCT04368143** · — · COMPLETED · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 84 (actual)

## Conditions studied

- COVID
- SARS-CoV 2
- Corona Virus Infection
- RDT
- B Cell

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04368143
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2021-12-02
- **Final completion:** 2021-12-02
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04368143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04368143, "COVID-19 Immune Repertoire Sequencing". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04368143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*